CD200R1 Antibody (OX108) [FITC] - Chimeric
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-52642F
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
CyTOF-ready, Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Kappa Clone # OX108
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CD200R1 Antibody (OX108) [FITC] - Chimeric
Immunogen
Recombinant protein - hCD200RCD4d3+4.
Reactivity Notes
Human
Specificity
Recognizes human CD200R, a receptor for the CD200/OX2.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Applications for CD200R1 Antibody (OX108) [FITC] - Chimeric
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD200R1
Long Name
CD200 Receptor 1
Alternate Names
CD200 R1, MOX2R
Gene Symbol
CD200R1
Additional CD200R1 Products
Product Documents for CD200R1 Antibody (OX108) [FITC] - Chimeric
Product Specific Notices for CD200R1 Antibody (OX108) [FITC] - Chimeric
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...